Mi Zhou

1.9k total citations
72 papers, 1.3k citations indexed

About

Mi Zhou is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Mi Zhou has authored 72 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Mi Zhou's work include Antifungal resistance and susceptibility (8 papers), RNA and protein synthesis mechanisms (5 papers) and RNA modifications and cancer (5 papers). Mi Zhou is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), RNA and protein synthesis mechanisms (5 papers) and RNA modifications and cancer (5 papers). Mi Zhou collaborates with scholars based in China, United States and France. Mi Zhou's co-authors include Wenjing Wang, Daqiang Yuan, Ling Yin, Yang Song, Min Zhang, Yiyi Zhou, Yun Lu, Renxiao Wang, Xianyun Sun and Chengcheng Hu and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Mi Zhou

67 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mi Zhou China 19 443 227 180 164 154 72 1.3k
Qianqian Kong China 21 594 1.3× 489 2.2× 117 0.7× 52 0.3× 75 0.5× 77 1.4k
Marc Le Borgne France 29 827 1.9× 157 0.7× 223 1.2× 44 0.3× 44 0.3× 110 2.3k
Huaibin Zhang China 21 583 1.3× 326 1.4× 33 0.2× 160 1.0× 44 0.3× 60 1.4k
Sang Hwa Lee South Korea 24 484 1.1× 162 0.7× 48 0.3× 26 0.2× 41 0.3× 110 1.8k
Ashutosh Singh India 26 472 1.1× 384 1.7× 195 1.1× 106 0.6× 11 0.1× 63 1.7k
Xiufeng Zhang China 26 1.1k 2.5× 221 1.0× 38 0.2× 48 0.3× 30 0.2× 137 1.9k
Yali Cui China 19 232 0.5× 166 0.7× 25 0.1× 42 0.3× 69 0.4× 57 860
Huiyun Wang China 22 347 0.8× 152 0.7× 19 0.1× 61 0.4× 38 0.2× 87 1.3k
Tiantian Wei China 21 366 0.8× 224 1.0× 19 0.1× 66 0.4× 48 0.3× 90 1.2k
Yang He China 26 1.2k 2.6× 148 0.7× 68 0.4× 38 0.2× 23 0.1× 130 2.4k

Countries citing papers authored by Mi Zhou

Since Specialization
Citations

This map shows the geographic impact of Mi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Zhou more than expected).

Fields of papers citing papers by Mi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Zhou. The network helps show where Mi Zhou may publish in the future.

Co-authorship network of co-authors of Mi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Zhou. A scholar is included among the top collaborators of Mi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Zhou. Mi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zha, Yukun, Peishen Zhao, Owen L. Woodman, et al.. (2025). FPR2 Agonism Attenuates Restenosis by Mitigating Neointimal Hyperplasia via ELOVL6. The FASEB Journal. 39(17). e71020–e71020. 1 indexed citations
2.
Dong, Jie, Haibo Li, Mi Zhou, et al.. (2024). Four new diarylheptanoids and two new terpenoids from the fruits of Alpinia oxyphylla and their anti-inflammatory activities. Chinese Journal of Natural Medicines. 22(10). 929–936. 3 indexed citations
3.
Yu, Ping, Shuting Ye, Mi Zhou, et al.. (2024). PWWP domain-containing protein Crf4-3 specifically modulates fungal azole susceptibility by regulating sterol C-14 demethylase ERG11. mSphere. 10(1). e0070324–e0070324. 1 indexed citations
4.
Zhou, Mi, Ping Yu, Chengcheng Hu, et al.. (2024). Suppressed Protein Translation Caused by MSP‐8 Deficiency Determines Fungal Multidrug Resistance with Fitness Cost. Advanced Science. 12(6). e2412514–e2412514.
5.
6.
Zheng, Meizhu, et al.. (2023). TMT and PRM Based Quantitative Proteomics to Explore the Protective Role and Mechanism of Iristectorin B in Stroke. International Journal of Molecular Sciences. 24(20). 15195–15195. 1 indexed citations
7.
Li, Jinyong, Xuan Tian, Wei Jia, et al.. (2023). Clinical outcomes of AngioJet pharmacomechanical thrombectomy versus catheter-directed thrombolysis for the treatment of filter-related caval thrombosis. World Journal of Clinical Cases. 11(3). 598–609. 4 indexed citations
8.
Duan, Zhu, Mi Zhou, Hou-Li Zhang, et al.. (2023). Network analysis identifies a gene biomarker panel for sepsis-induced acute respiratory distress syndrome. BMC Medical Genomics. 16(1). 165–165. 2 indexed citations
9.
Liu, Liu, Siting Chen, Jiao Wang, et al.. (2022). Fibrinogen-Like Protein 1 as a Novel Biomarker of Psoriasis Severity. Journal of Inflammation Research. Volume 15. 4637–4647. 9 indexed citations
10.
Zhou, Mi, et al.. (2021). Plasma Metabolic Profiling in Patients With Silicosis and Asbestosis. Journal of Occupational and Environmental Medicine. 63(9). 787–793. 12 indexed citations
11.
Zhou, Mi, et al.. (2021). Genome editor-directed in vivo library diversification. Cell chemical biology. 28(8). 1109–1118. 11 indexed citations
12.
Zhou, Mi, et al.. (2021). Harnessing the power of directed evolution to improve genome editing systems. Current Opinion in Chemical Biology. 64. 10–19. 2 indexed citations
13.
Li, Jing, Yannan Wang, Beisi Xu, et al.. (2020). Intellectual disability‐associated gene ftsj1 is responsible for 2′‐O‐methylation of specific tRNAs. EMBO Reports. 21(8). e50095–e50095. 39 indexed citations
14.
Song, Yang, Min Zhang, Ling Yin, et al.. (2020). COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2). International Journal of Antimicrobial Agents. 56(2). 106080–106080. 150 indexed citations
15.
Ni, Zhengyi, Ali Wang, Zhenxing Liu, et al.. (2019). Three novel compound heterozygous IL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease. PLoS ONE. 14(4). e0215648–e0215648. 6 indexed citations
16.
Hu, Chengcheng, Mi Zhou, Wenzhao Wang, et al.. (2018). Abnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles. Frontiers in Microbiology. 9. 9–9. 86 indexed citations
17.
Wang, Wenjing, Mi Zhou, & Daqiang Yuan. (2016). Carbon dioxide capture in amorphous porous organic polymers. Journal of Materials Chemistry A. 5(4). 1334–1347. 260 indexed citations
18.
Wang, Xuefeng, Chen Zhang, Xiangming Yan, et al.. (2015). A Novel Bioavailable BH3 Mimetic Efficiently Inhibits Colon Cancer via Cascade Effects of Mitochondria. Clinical Cancer Research. 22(6). 1445–1458. 28 indexed citations
19.
Wang, Jue, Mi Zhou, Zheng Hu, et al.. (2015). TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality. Scientific Reports. 5(1). 18454–18454. 9 indexed citations
20.
Liu, Zhen, Yan Li, Mi Zhou, et al.. (2011). Synthesis and anti-tumor activities of N′-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone derivatives. Bioorganic & Medicinal Chemistry Letters. 21(22). 6662–6666. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qianqian Kong Breakdown of academic impact, for papers by Marc Le Borgne Breakdown of academic impact, for papers by Huaibin Zhang Breakdown of academic impact, for papers by Sang Hwa Lee Breakdown of academic impact, for papers by Ashutosh Singh Breakdown of academic impact, for papers by Xiufeng Zhang Breakdown of academic impact, for papers by Yali Cui Breakdown of academic impact, for papers by Huiyun Wang Breakdown of academic impact, for papers by Tiantian Wei Breakdown of academic impact, for papers by Yang He
Rankless by CCL
2026